Directory Last Updated: 20 November 2024
Return to Directory Key Opinion Leaders Special Interests word selected:- NEW
Names, CVs (as available), locations and contact details of Investigators are available to Subscribers.
To subscribe, please contact Emma Taylor at emma@specialistinfo.com or 01423 727 724 for details on subscription costs.
Page No 1
PhraseConsultantTownSpecial Interests
Civil Aviation Authority New Zealand
*Consultant(s)*
*Towns*Aviation medicine and occupational medicine, authorised medical examiner for UK Civil Aviation Authority, EASA - European Aviation Safety Agency, US Federal Aviation Administration, Transport Canada, Civil Aviation Authority South Africa, Civil Aviation Authority New Zealand, CAD Hong Kong
clinical trials of new agents
*Consultant(s)*
*Towns*Non surgical treatment of prostate cancer, prostate iodine seed brachytherapy, image-guided intensity modulated external beam radiotherapy for prostate cancer, chemotherapy and systemic therapy for prostate cancer, bladder cancer chemotherapy and radiotherapy, clinical trials of new agents, prostate stereotactic body radiotherapy, focal salvage seed brachytherapy
development of new treatments for psychosis
*Consultant(s)*
*Towns*Mechanisms underlying psychotic symptoms and psychosis, development of new treatments for psychosis
Glaucoma - new devices
*Consultant(s)*
*Towns*Glaucoma - new devices, digital technology in ophthalmology, minimally invasive glaucoma surgery, new devices and pharmaceutical therapies for cataract surgery, new innovations in ophthalmology
new devices and pharmaceutical therapies for cataract surgery
*Consultant(s)*
*Towns*Glaucoma - new devices, digital technology in ophthalmology, minimally invasive glaucoma surgery, new devices and pharmaceutical therapies for cataract surgery, new innovations in ophthalmology
new diagnostic platforms for STIs
*Consultant(s)*
*Towns*HIV medicine, epidemiology of sexually transmitted infections, clinical e-health, new diagnostic platforms for STIs
new diagnostics
*Consultant(s)*
*Towns*Control of infection, HIV, septic shock, antifungal therapy, new diagnostics, infectious diseases, antibiotic resistance
new diminished responsibility
*Consultant(s)*
*Towns*Fitness to plead, new diminished responsibility, adult ADHD, autism spectrum disorder and Asperger's in prisons and secure forensic psychiatric units
new drug development in paediatric oncology
*Consultant(s)*
*Towns*Brain tumours in childhood, liver tumours in childhood, bone and soft tissue tumours in childhood, new drug development in paediatric oncology
new drugs in type 2 diabetes
*Consultant(s)*
*Towns*Diabetic nephropathy, new drugs in type 2 diabetes, Type 1 diabetes mellitis immunotherapy, dietary management of diabetes and obesity
new innovations in ophthalmology
*Consultant(s)*
*Towns*Glaucoma - new devices, digital technology in ophthalmology, minimally invasive glaucoma surgery, new devices and pharmaceutical therapies for cataract surgery, new innovations in ophthalmology
new treatment of Type 2 diabetes
*Consultant(s)*
*Towns*Obesity, impotence, thyroid, pituitary, new treatment of Type 2 diabetes, insulin pump therapy, hirsutism, obesity
new treatments for wet macular degeneration
*Consultant(s)*
*Towns*Small incision cataract surgery - phacoemulsification, retinal diseases, AMD - age-related macular degeneration, diabetic eye diseases, uveitis, laser treatments, photodynamic therapy, glaucoma, new treatments for wet macular degeneration
Page No 1
Spacer

Third Party Advertisement

Adverts by Google